The AMPA-VEGA 1 study for depression
A randomised, double-blind, placebo-controlled study to evaluate the maintenance of effect of NBI‑1065845 as an adjunctive treatment in subjects with major depressive disorder (MDD)
If your current antidepressant medication(s) is/are not adequately improving symptoms of your major depressive disorder (MDD), you may be eligible for the AMPA-VEGA 1 study. This study is researching an investigational medication to see if it is safe and whether it improves symptoms of MDD when taken with your current antidepressant medication(s).
To learn more about the AMPA-VEGA 1 study, download the brochure below or contact us: AIMClinic-AMPAVEGA@unimelb.edu.au
